1. Home
  2. EFC vs ABCL Comparison

EFC vs ABCL Comparison

Compare EFC & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EFC
  • ABCL
  • Stock Information
  • Founded
  • EFC 2007
  • ABCL 2012
  • Country
  • EFC United States
  • ABCL Canada
  • Employees
  • EFC N/A
  • ABCL N/A
  • Industry
  • EFC Real Estate
  • ABCL Biotechnology: Pharmaceutical Preparations
  • Sector
  • EFC Finance
  • ABCL Health Care
  • Exchange
  • EFC Nasdaq
  • ABCL Nasdaq
  • Market Cap
  • EFC 1.4B
  • ABCL 1.1B
  • IPO Year
  • EFC 2010
  • ABCL 2020
  • Fundamental
  • Price
  • EFC $13.44
  • ABCL $5.69
  • Analyst Decision
  • EFC Strong Buy
  • ABCL Strong Buy
  • Analyst Count
  • EFC 7
  • ABCL 5
  • Target Price
  • EFC $14.46
  • ABCL $8.00
  • AVG Volume (30 Days)
  • EFC 1.6M
  • ABCL 5.8M
  • Earning Date
  • EFC 11-05-2025
  • ABCL 11-06-2025
  • Dividend Yield
  • EFC 11.60%
  • ABCL N/A
  • EPS Growth
  • EFC N/A
  • ABCL N/A
  • EPS
  • EFC 1.24
  • ABCL N/A
  • Revenue
  • EFC $312,485,000.00
  • ABCL $32,875,999.00
  • Revenue This Year
  • EFC N/A
  • ABCL $16.99
  • Revenue Next Year
  • EFC $7.92
  • ABCL $63.73
  • P/E Ratio
  • EFC $10.86
  • ABCL N/A
  • Revenue Growth
  • EFC 10.76
  • ABCL N/A
  • 52 Week Low
  • EFC $11.12
  • ABCL $1.89
  • 52 Week High
  • EFC $14.40
  • ABCL $6.41
  • Technical
  • Relative Strength Index (RSI)
  • EFC 56.21
  • ABCL 65.77
  • Support Level
  • EFC $12.75
  • ABCL $4.51
  • Resistance Level
  • EFC $13.50
  • ABCL $6.41
  • Average True Range (ATR)
  • EFC 0.22
  • ABCL 0.34
  • MACD
  • EFC 0.04
  • ABCL 0.11
  • Stochastic Oscillator
  • EFC 92.67
  • ABCL 62.11

About EFC Ellington Financial Inc.

Ellington Financial Inc is a specialty finance company. Its primary investment objective is to generate attractive, risk-adjusted total returns for its shareholders by making investments. The company has two reportable segments; The Investment Portfolio Segment is focused on investing in a diverse array of financial assets, including residential and commercial mortgage loans, residential mortgage-backed securities, non-mortgage- and mortgage-related derivatives, debt and equity investments in loan origination companies, and other strategic investments, and The Longbridge Segment is focused on the origination and servicing of reverse mortgage loans. it acquires reverse mortgage loans both through its origination activities and through secondary market purchases.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

Share on Social Networks: